Delivery Order SPE2DB25D3008-SPE2DB25FRCWR
Award Date 8/7/25
Potential Completion Date 8/28/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,699.64 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, utilizing firm fixed-price pricing, covers the supply of Xeomin 100 unit vials and is scheduled for completion by August 27, 2025. The award was made through open competition with no set-aside designation, with performance taking place at the vendor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 14, 2025, for the supply of Xeomin 200 Unit Vials valued at $93,868.32, with completion scheduled for August 4, 2025. This competitively awarded, firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation. The contract reflects the Defense Department's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $93,868.32 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xeomin 200 Unit Vials. The contract, awarded on August 7, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,401.24 on September 17, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price contract, with an ultimate completion date of October 8, 2025, was awarded without a set-aside designation through competitive procurement. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the Department of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Xeomin 100 unit vials. The contract is valued at $2,793.70 and carries a firm fixed price structure with an ultimate completion date of August 13, 2025. This non-set-aside award represents a competitive procurement action and will be performed at the contractor's Conshohocken facility....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,057.32 by the Defense Logistics Agency on June 2, 2025, for the supply of Xeomin 100 unit vials, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $2,588.04 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xeomin 100 unit vials, with an ultimate completion date of October 7, 2025. This competitive delivery order utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which also serves as AmerisourceBergen's corporate headquarters. This award represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,174.80 on August 15, 2025, for the supply of Xeomin 100 Unit Vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 8, 2025, and is being funded through the Defense Medical Supply Chain, which supports pharmaceutical procurement for military and veteran healthcare systems. The award represents a child delivery order under...